Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma

Niranjan Yanamandra1, Mark A Berhow, Santhi Konduri

  • 1Division of Cancer Biology, Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine at Peoria, Peoria, Illinois 61605, USA.

Insights

Soybean saponins, specifically soyasapogenol B glycosides, show significant anti-cancer effects. These compounds reduce human glioblastoma cell invasion and induce apoptosis by activating key cellular death pathways.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Growing interest in dietary compounds for chronic disease prevention.
  • Saponins are recognized for their time-dependent anti-cancer properties.

Purpose of the Study:

  • To investigate the anti-invasive and pro-apoptotic effects of a purified soyasapogenol B glycoside fraction from soybeans.
  • To elucidate the molecular mechanisms underlying these effects in human glioblastoma cells.

Main Methods:

  • In vitro Matrigel invasion assay using SNB 19 human glioblastoma cells.
  • Assessment of mitochondrial function, including membrane potential and cytochrome c release.
  • Analysis of caspase activation (caspase-9, caspase-3) and poly ADP-ribose polymerase (PARP) cleavage.

Main Results:

  • A 45% reduction in SNB 19 cell invasion was observed with the saponin fraction.
  • Triterpenoid saponin treatment induced dose-dependent loss of mitochondrial membrane potential.
  • Evidence of apoptosis induction through cytochrome c release and caspase cascade activation.

Conclusions:

  • Soyasapogenol B glycosides possess significant anti-invasive properties against human glioblastoma cells.
  • These saponins effectively induce apoptosis in glioblastoma cells via the mitochondrial pathway and caspase activation.
  • The findings highlight the potential of soybean-derived saponins as anti-cancer agents.

Related Concept Videos